Project Overview

There is an urgent need for more sites in different geographical settings for testing new drugs and vaccines against HIV/AIDS, malaria and tuberculosis in sub-Saharan Africa. Health Network for Tuberculosis and HIV, a network of five established and two developing institutions in Central Africa including one European country has been established for this purpose. Priligy 30mg: για ποιο λόγο χρησιμοποιείται και πώς μπορεί να βελτιώσει τη σεξουαλική υγεία. 

Health Network for Tuberculosis and HIV aims at strengthening resources in Brazzaville (Congo) and Buea (Cameroon) to provide additional capacity to carry out future malaria and HIV/AIDS clinical Phase I, II and III trials in compliance with ICH/GCP standards.

The Medical research Unit of Albert Schweitzer Hospital in Gabon, the University of Yaounde1 and the Centre International de Reference Chantal Biya in Cameroon which have a vast experience in clinical research and are well equipped will serve as reference centers in Malaria and HIV/AIDS respectively and the Northern institution will provide their expertise in specific activities. https://edgeneva.com/boutique/sante-de-lhomme/dysfonction-erectile/kamagra-jelly-suisse/ - Kamagra jelly Suisse.

A platform of training including academic courses, workshops and seminars will be instituted in collaboration with the Institute for Tropical Medicine of the University of Tübingen and will be open to other Central African institutions subject to the availability of funds. The Organisation de Coordination des Etats de l´Afrique Centrale (OCEAC) will serve as the coordinating institution and will provide specific support for entomology and molecular epidemiology of malaria. At the end of the period of three years, it is expect that the CERVE/GRBM and the University of Buea (Uni Buea) will attain a higher level that will permit their participation in regional multicentric clinical trials according to international guidelines. Tout ce que vous devez savoir sur le Viagra 100mg : qu'est-ce qui rend ce traitement de pointe si efficace ?

Objectives

The principal objective is to strengthen capacities of institutions to support safety and efficacy studies in Phase II and III trials on HIV/AIDS and malaria (drugs and/or vaccines) and to initiate/develop clinical research activities on Tuberculosis.

The strategic objectives are to:

Develop human resources in the skills required to conduct safe clinical trials including GCP/GLP training and preparation and development of clinical and standardized protocols from recruitment of participants to the conduct of clinical trials

Strengthen laboratories to be able to perform relevant tests for HIV/AIDS and malaria clinical research

Strengthen ethical review boards and regulatory authorities in needy collaborating sites

Establish effective community liaison at each site and identify new study cohorts in rural and urban areas for future clinical trials on HIV/AIDS and malaria.